Canada Markets closed

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.39000.0000 (0.00%)
At close: 8:00AM CEST
Full screen
Previous Close0.3900
Open0.3900
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3900 - 0.3900
52 Week Range0.1590 - 0.7150
Volume6,000
Avg. Volume251
Market Cap12.307M
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-0.0870
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    IIROC Trading Halt - PILL

    VANCOUVER, BC, Sept. 17, 2020 /CNW/ - The following issues have been halted by IIROC:Company: Canntab Therapeutics LimitedCSE Symbol: PILL All Issues: YesReason: At the request of the Company Pending NewsHalt Time (ET): 9:34 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.

  • Canntab announces planned purchases of cannabis processing equipment and leasehold improvements
    CNW Group

    Canntab announces planned purchases of cannabis processing equipment and leasehold improvements

    TORONTO, Aug. 21, 2020 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.

  • Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement
    CNW Group

    Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement

    TORONTO, June 2, 2020 /CNW/ - Canntab Therapeutics Limited (CSE:PILL.CN - News)(OTCQB:CTABF - News) (FRA:TBF1.F - News) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it is today beginning production of its instant release tablets and has already entered into its first purchase agreement with MediPharm Labs ("MediPharm") (TSX:LABS.TO - News)(OTCQX:MEDIF - News)(Deutsche Borse: MLZ), a global leader in pharma quality cannabinoid based products. Orders under the agreement will be composed of a mix of Canntab's proprietary instant release tablets delivering THC, CBD and a combination of THC/CBD in 12 different strengths. MediPharm will purchase and distribute cannabis products on a non-exclusive basis across Canada, through licensed provincial dispensaries.